Cargando…
ATT- A Double Edged Sword?
Antitubercular therapy (ATT) induced hepatotoxicity, although well known to clinicians, is often over looked and underrated. Given the low threshold of starting ATT, especially empirically, the adverse manifestations can take a considerable toll. A variety of associated risk factors compound the mor...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480752/ https://www.ncbi.nlm.nih.gov/pubmed/23112401 http://dx.doi.org/10.4103/0250-474X.100241 |
_version_ | 1782247611772698624 |
---|---|
author | Gude, D. Bansal, D. P. |
author_facet | Gude, D. Bansal, D. P. |
author_sort | Gude, D. |
collection | PubMed |
description | Antitubercular therapy (ATT) induced hepatotoxicity, although well known to clinicians, is often over looked and underrated. Given the low threshold of starting ATT, especially empirically, the adverse manifestations can take a considerable toll. A variety of associated risk factors compound the morbidity. We throw light on one such a case where ATT was detrimental to the patient and review the literature and possible preventive strategies. |
format | Online Article Text |
id | pubmed-3480752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-34807522012-10-30 ATT- A Double Edged Sword? Gude, D. Bansal, D. P. Indian J Pharm Sci Short Communications Antitubercular therapy (ATT) induced hepatotoxicity, although well known to clinicians, is often over looked and underrated. Given the low threshold of starting ATT, especially empirically, the adverse manifestations can take a considerable toll. A variety of associated risk factors compound the morbidity. We throw light on one such a case where ATT was detrimental to the patient and review the literature and possible preventive strategies. Medknow Publications & Media Pvt Ltd 2011 /pmc/articles/PMC3480752/ /pubmed/23112401 http://dx.doi.org/10.4103/0250-474X.100241 Text en Copyright: © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communications Gude, D. Bansal, D. P. ATT- A Double Edged Sword? |
title | ATT- A Double Edged Sword? |
title_full | ATT- A Double Edged Sword? |
title_fullStr | ATT- A Double Edged Sword? |
title_full_unstemmed | ATT- A Double Edged Sword? |
title_short | ATT- A Double Edged Sword? |
title_sort | att- a double edged sword? |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480752/ https://www.ncbi.nlm.nih.gov/pubmed/23112401 http://dx.doi.org/10.4103/0250-474X.100241 |
work_keys_str_mv | AT guded attadoubleedgedsword AT bansaldp attadoubleedgedsword |